All resources are organized into categories. Click the arrow to reveal the subcategories within each category. Click any category or subcategory to view all the resources it contains.
Text search
Enter words or phrases to search for resources. Note: This searches on the resource titles and descriptions, but does not currently search the content of the resources (e.g., the text in a PDF).
Advanced Search
Tick the boxes to search any combination of category, resource format, author, publication date, and whether a resource is peer reviewed or available in French. As you check and uncheck items, the count of matching resources will update. Click the blue “SHOW RESULTS” button to view resources that match the criteria you have selected.
Results 4 Informed Choice is a resource for HIV and family planning program implementers, government representatives, advocates and journalists as they respond to the results from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial.
The trial results, released June 13, 2019, showed that none of the three contraceptive methods in the trial increased the risk of HIV acquisition. Other findings, including high HIV incidence across the study arms and broad acceptability and effectiveness of the contraceptive methods, are a call to action for greater attention to and investment in women’s health, HIV prevention and contraceptive choice. Full findings from the study can be found in the Lancet article.
The tools, resources and data are intended to help stakeholders plan and execute their response so that women have all the information they need to make an informed choice in adopting and using a contraceptive method and protecting themselves from HIV.
The World Health Organization (WHO) convened a Guideline Development Group (GDG) meeting from 29 to 31 July 2019 to review global guidance on contraceptive eligibility for women at high risk of HIV acquisition to and determine whether revisions to the fifth edition of the Medical eligibility criteria for contraceptive use (MEC) were needed. The issue was deemed critical, particularly for sub-Saharan Africa, given the high lifetime risk of acquiring HIV alongside the importance of hormonal contraception in offering women and adolescent girls’ choice and in reducing their risk of unintended pregnancy, a common threat to the health, well-being and lives of women and adolescent girls.
Summarizes important takeaways for advocates from the latest guidance released by the World Health Organization on hormonal contraception, including DMPA injectables, and HIV for women at high risk of HIV.
In 2019, the Evidence to Practice meeting provided an opportunity to sustain progress and ensure that women have access to this contraceptive innovation as quickly as possible. Delegates from 20 countries across Africa and Asia attended sessions on the state of global scale-up, self-injection evidence and best practices, family planning and HIV integration, the role of the private sector, skills building (monitoring, learning, and evaluation; commodity forecasting; and advocacy), demand generation, innovative training approaches, and a conversation with five DMPA-SC donors.
The Implementation Guide for the Medical eligibility criteria for contraceptive use (MEC) and Selected practice recommendations for contraceptive use (SPR) is part of a global initiative to translate guidance into practice, through implementation science principles. The Implementation Guide is designed to provide a structured process to aid countries’ efforts to incorporate the World Health Organization Medical eligibility criteria for contraceptive use (MEC) and Selected practice recommendations for contraceptive use (SPR) (and their updates) into national family planning guidance. The Toolkit provides the practical resources needed to achieve the tasks in the Implementation Guide.
